Search the DCP's clinical trials database for ongoing clinical trials in prevention, early detection, and the management of symptoms related to cancer and its treatments.
| Title | Intervention | Sponsor Sort descending | Status |
|---|---|---|---|
| Couple-Based Meditation for Metastatic Lung Cancer Patients and Their Partners | Cancer-Related Discussion Program, Questionnaires, Meditation and Discussion Sessions | M.D. Anderson Cancer Center | Recruiting |
| ASPirin Intervention for the REDuction of Colorectal Cancer Risk | Placebo for Aspirin, Aspirin | Massachusetts General Hospital | Active, not recruiting |
| Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer | Blood sample, Pap smear, Uterine lavage, or a wash of the womb | Massachusetts General Hospital | Recruiting |
| ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension | Aspirin, Placebo | Massachusetts General Hospital | Active, not recruiting |
| Treating Breast Cancer Patients Undergoing Trastuzumab Treatment With Carvedilol to Reduce Incidence of Heart Failure | Carvedilol | Mayo Clinic | Active, not recruiting |
| Cohort Study of Pancreatic Cancer Risk | Mayo Clinic | Active, not recruiting | |
| Molecular Detection of Advanced Neoplasia in Pancreatic Cysts | Pancreatic Surgery, Blood, stool, pancreatic juice and cyst fluid collection, Endoscopy Exam | Mayo Clinic | Recruiting |
| Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer | Biopsy, Biospecimen Collection, Low-Dose Aspirin, Questionnaire Administration | Mayo Clinic | Recruiting |
| A Collaborative Intervention for Improving Cancer Pain Management in Cancer Survivors (ASCENT) | Best Practice, Cancer Pain Management, Educational Intervention, Electronic Health Record Review, Health Telemonitoring, Questionnaire Administration | Mayo Clinic | Recruiting |
| Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts | Non-Interventional Study | Mayo Clinic | Recruiting |
| Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma | Sponge Capsule | Mayo Clinic | Recruiting |
| Minimally Invasive Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Cancer, SOS5C Trial | Cancer Screening, Computer-Assisted Intervention, Endoscopic Procedure, Health Risk Assessment, Navigation, Questionnaire Administration | Mayo Clinic | Not yet recruiting |
| Minimally Invasive Molecular Approaches for the Detection of Barrett's Esophagus- High Grade Dysplasia and Esophageal Adenocarcinoma | Non-Interventional Study | Mayo Clinic | Enrolling by invitation |
| Meaning-Centered Counseling for Chinese Patients Who Are Being Treated for Advanced Cancer | Adaptation of IMCP for Chinese Immigrant Cancer Patients, In-depth Patient Interviews, Individual Meaning-Centered Psychotherapy for Chinese (IMCP-Ch) (For Phase 3 and Phase 4) | Memorial Sloan Kettering Cancer Center | Active, not recruiting |
| CHARM II: Chemotherapy for Ablation and Resolution of Mucinous Pancreatic Cysts | Ethanol, Normal saline, Paclitaxel + Gemcitabine admixture | Milton S. Hershey Medical Center | Active, not recruiting |
| Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion | Laboratory Biomarker Analysis, Metformin Hydrochloride | National Cancer Institute (NCI) | Active, not recruiting |
| NCI COVID-19 in Cancer Patients, NCCAPS Study | Biospecimen Collection, Data Collection, Quality-of-Life Assessment, Questionnaire Administration | National Cancer Institute (NCI) | Active, not recruiting |
| Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis | Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Placebo Administration, Questionnaire Administration, Simvastatin | National Cancer Institute (NCI) | Active, not recruiting |
| Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia | Curcumin, Laboratory Biomarker Analysis, Placebo Administration, Quality-of-Life Assessment | National Cancer Institute (NCI) | Active, not recruiting |
| DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection | Electroporation-Mediated Plasmid DNA Vaccine Therapy, HCV DNA Vaccine INO-8000, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Rocakinogene Sifuplasmid | National Cancer Institute (NCI) | Active, not recruiting |